Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices 1335 

9See Certification of Factual Information To 

Import Administration During Antidumping and 

Countervailing Duty Proceedings, 78 FR 42678 (July 

17, 2013) (Final Rule); see also the frequently asked 

questions regarding the Final Rule, available at 

http://enforcement.trade.gov/tlei/notices/factual_

info_final_rule_FAQ_07172013.pdf. 

for the revised certifications provided at 

the end of the Final Rule.9 Commerce 

intends to reject factual submissions in 

any proceeding segments if the 

submitting party does not comply with 

applicable revised certification 

requirements. 

Extension of Time Limits Regulation 

Parties may request an extension of 

time limits before a time limit 

established under Part 351 expires, or as 

otherwise specified by the Secretary. 

See 19 CFR 351.302. In general, an 

extension request will be considered 

untimely if it is filed after the time limit 

established under Part 351 expires. For 

submissions which are due from 

multiple parties simultaneously, an 

extension request will be considered 

untimely if it is filed after 10:00 a.m. on 

the due date. Examples include, but are 

not limited to: (1) Case and rebuttal 

briefs, filed pursuant to 19 CFR 351.309; 

(2) factual information to value factors 

under 19 CFR 351.408(c), or to measure 

the adequacy of remuneration under 19 

CFR 351.511(a)(2), filed pursuant to 19 

CFR 351.301(c)(3) and rebuttal, 

clarification and correction filed 

pursuant to 19 CFR 351.301(c)(3)(iv); (3) 

comments concerning the selection of a 

surrogate country and surrogate values 

and rebuttal; (4) comments concerning 

U.S. Customs and Border Protection 

data; and (5) quantity and value 

questionnaires. Under certain 

circumstances, Commerce may elect to 

specify a different time limit by which 

extension requests will be considered 

untimely for submissions which are due 

from multiple parties simultaneously. In 

such a case, Commerce will inform 

parties in the letter or memorandum 

setting forth the deadline (including a 

specified time) by which extension 

requests must be filed to be considered 

timely. This modification also requires 

that an extension request must be made 

in a separate, stand-alone submission, 

and clarifies the circumstances under 

which Commerce will grant untimelyfiled requests for the extension of time 

limits. These modifications are effective 

for all segments initiated on or after 

October 21, 2013. Please review the 

final rule, available at http://

www.gpo.gov/fdsys/pkg/FR-2013-09-20/ 

html/2013-22853.htm, prior to 

submitting factual information in these 

segments. 

These initiations and this notice are 

in accordance with section 751(a) of the 

Act (19 U.S.C. 1675(a)) and 19 CFR 

351.221(c)(1)(i). 

Dated: January 8, 2018. 

James Maeder, 

Senior Director performing the duties of 

Deputy Assistant Secretary for Antidumping 

and Countervailing Duty Operations. 

[FR Doc. 2018–00356 Filed 1–10–18; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

National Institute of Standards and 

Technology 

Notice of NIST’s Consortium for the 

Advancement of Genome Editing 

AGENCY: National Institute of Standards 

and Technology. 

ACTION: Notice of Research Consortium. 

SUMMARY: The National Institute of 

Standards and Technology (NIST), an 

agency of the United States Department 

of Commerce is establishing the Genome 

Editing Consortium with the goal of 

bringing together stakeholders across 

the genome editing community to 

identify and address measurement and 

standards needs to support this 

technical area. The Consortium intends 

to evaluate genome editing assay 

pipelines, develop benchmark materials, 

generate benchmark data, develop 

suggested minimal information 

reporting for public studies, and 

generate a common lexicon for genome 

editing studies, with the intent these 

resources can be used to increase 

confidence in evaluating genome editing 

and lower the risk to utilizing these 

technologies in research and 

commercial products. Participation fees 

will be at least $20,000 annually or inkind contributions of equivalent value. 

Participants will be required to sign a 

Cooperative Research and Development 

Agreement (CRADA). 

DATES: NIST will accept letters of 

interest containing required information 

for participation in this Consortium 

until January 1, 2020. Acceptance of 

participants into the Consortium after 

the Commencement Date will depend 

on eligibility as determined by NIST 

based upon the information provided in 

the letter of interest and upon the 

availability resources. 

ADDRESSES: Information in response to 

this notice, including completed letters 

of interest or requests for additional 

information about the Consortium can 

be directed via mail to the Consortium 

Manager, Dr. Samantha Maragh, 

Biosystems and Biomaterials Division of 

NIST’s Material Measurement 

Laboratory, 100 Bureau Drive, Mail Stop 

8312, Gaithersburg, Maryland 20899, or 

via electronic mail to samantha@

nist.gov, or by telephone at (301) 975– 

4947. 

FOR FURTHER INFORMATION CONTACT: For 

further information about participation 

opportunities to join the Genome 

Editing Consortium, please contact 

Jeffrey DiVietro, CRADA Officer, 

National Institute of Standards and 

Technology’s Technology Partnerships 

Office, by mail to 100 Bureau Drive, 

Mail Stop 2200, Gaithersburg, Maryland 

20899, by electronic mail to 

jeffrey.divietro@nist.gov, or by 

telephone at (301) 975–8779. 

SUPPLEMENTARY INFORMATION: Targeted 

Genome Editing is a technology space 

where there is a great need for reliable 

measurement methods for assuring the 

results of editing. Modalities for targeted 

genome editing include but are not 

limited to Zinc Finger Proteins (ZFPs), 

Homing Endonucleases, Transcription 

Activator-Like Nucleases (TALENs) and 

Clustered, Regularly Interspaced 

Palindromic Repeats (CRISPR). These 

technologies are being actively pursued 

by industry, academic, government and 

non-profit sectors to advance medicine 

and bioscience in areas such as: 

Regenerative medicine, synthetic 

biology, novel antimicrobials and 

antivirals, protein therapeutic 

biomanufacturing, agriculture and 

global food production. Utilizing these 

technologies for production and 

medicine will first require robust 

quantitative assays and measurements 

to enable high confidence 

characterization of DNA alterations 

resulting from genome editing. 

NIST has reached out to companies to 

assess their measurement needs, and 

has co-led workshops that have brought 

together experts across the genome 

editing field including stakeholders in 

industry, academia and government. 

These discussions have identified 

common pre-competitive measurement 

needs that if resolved can push forward 

the field as it relates to understanding 

the reliability of data from assays being 

used to measuring aspects of genome 

edited cells. 

This Consortium’s purpose is to 

develop measurement solutions and 

standards to advance confidence in 

measurements supporting the genome 

editing technology space. 

The Consortium will have three 

working groups with the following 

responsibilities: 

(1) Specificity Measurements: 

a. Design, generate, and evaluate a set 

of purified DNA samples and mixtures 


srobinson on DSK9F5VC42PROD with NOTICES
1336 Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices 

that can be used to mimic both of ontarget and off-target genome editing 

induced variants at known frequencies 

in a background of human genomic 

DNA which can be used to benchmark 

validation of sequencing pipelines 

intended to identify genome editing 

induced variants. 

b. Design and conduct controlled 

evaluations of assays intended to 

identify where genome editing enzymes 

have been active in a genome, with an 

experimental design that allows for 

enough power to assess the sources of 

variability, repeatability, and 

reproducibility within an assay. 

(2) Data and Meta Data: 

a. Identify community norms for data 

formats and tools for benchmarking data 

analysis including in silico data sets and 

an experimental data set. 

b. Determine the type of meta data 

that would be needed to be shared, 

housed, and interrogated from genome 

editing experiments. 

(3) Lexicon: Identify terms and related 

definitions to form a common genome 

editing community lexicon. 

No proprietary information will be 

shared as part of the Consortium. 

Process: Interested parties with 

relevant genome editing associated 

capabilities (see below), products, and/ 

or technical expertise to support this 

Consortium should contact NIST using 

the information provided in the 

ADDRESSES section of this notice. NIST 

will then provide each interested party 

with a letter of interest template, which 

the party must complete, and submit to 

NIST. NIST will contact interested 

parties if there are questions regarding 

the responsiveness of the letters. NIST 

will select participants who have 

submitted complete letters of interest 

based on the capabilities listed below. 

Eligibility will be determined solely by 

NIST based on information provided by 

interested organizations and upon the 

availability of necessary resources to 

NIST. 

To participate, the eligible applicant 

will be required to sign a CRADA with 

NIST. 

Requirements: Each letter of interest 

should provide the following 

information: 

(1) A description of the experience in 

genome editing or genome engineering, 

bioinformatics, next-generation 

sequencing, detection or quantitation of 

DNA variants or related expertise to 

contribute to the Consortium. 

(2) Subgroups or topic areas of 

interest for participation. There is no 

limit on the number of areas of 

participation. 

(3) List of interested party’s 

anticipated participants. 

Letters of interest may not include 

business proprietary information. NIST 

will not treat any information provided 

in response to this Notice as proprietary 

information. NIST will notify each 

organization of its eligibility. In order to 

participate in this Consortium, each 

eligible organization must sign a 

CRADA for this Consortium. All 

participants to this Consortium will be 

bound by the same terms and 

conditions. Participants will be required 

to contribute financial or equivalent inkind resources, as determined by NIST, 

of at least $20,000. NIST does not 

guarantee participation in the 

Consortium or in any other 

collaboration to any organization 

submitting a Letter of Interest. 

Authority: 15 U.S.C. 3710a. 

Kevin Kimball, 

NIST Chief of Staff. 

[FR Doc. 2018–00315 Filed 1–10–18; 8:45 am] 

BILLING CODE 3510–13–P 

DEPARTMENT OF COMMERCE 

National Oceanic and Atmospheric 

Administration 

RIN 0648–XF917 

Fisheries of the South Atlantic; South 

Atlantic Fishery Management Council; 

Public Meetings 

AGENCY: National Marine Fisheries 

Service (NMFS), National Oceanic and 

Atmospheric Administration (NOAA), 

Commerce. 

ACTION: Notice of meeting of the South 

Atlantic Fishery Management Council’s 

Citizen Science Advisory Panel 

Projects/Topics Management; Finance & 

Infrastructure; Volunteers; 

Communication/Outreach/Education; 

and Data Management Action Teams. 

SUMMARY: The South Atlantic Fishery 

Management Council (Council) will 

hold an all-hands meeting of its Citizen 

Science Advisory Panel Projects/Topics 

Management; Finance & Infrastructure; 

Volunteers; Communication/Outreach/ 

Education; and Data Management 

Action Teams via webinar. 

DATES: The Projects/Topics 

Management; Finance & Infrastructure; 

Volunteers; Communication/Outreach/ 

Education; and Data Management 

Action Team meeting will be held on 

Wednesday, January 31, 2018 at 9 a.m. 

The meeting is scheduled to last 

approximately three hours. Additional 

Action Team webinar dates and times 

will publish in a subsequent issue in the 

Federal Register. 

ADDRESSES: 

Meeting address: The meeting will be 

held via webinar and is open to 

members of the public. Webinar 

registration is required and registration 

links will be posted to the Citizen 

Science program page of the Council’s 

website at www.safmc.net. 

Council address: South Atlantic 

Fishery Management Council, 4055 

Faber Place Drive, Suite 201, N 

Charleston, SC 29405. 

FOR FURTHER INFORMATION CONTACT: 

Amber Von Harten, Citizen Science 

Program Manager, SAFMC; phone (843) 

302–8433 or toll free (866) SAFMC–10; 

fax: (843) 769–4520; email: 

amber.vonharten@safmc.net. 

SUPPLEMENTARY INFORMATION: The 

Council created a Citizen Science 

Advisory Panel Pool in June 2017. The 

Council appointed members of the 

Citizen Science Advisory Panel Pool to 

five Action Teams in the areas of 

Volunteers, Data Management, Projects/ 

Topics Management, Finance, and 

Communication/Outreach/Education to 

develop program policies and 

operations for the Council’s Citizen 

Science Program. 

Each Action Team has been meeting 

since August 2017 to work on 

developing recommendations on 

program policies and operations to be 

reviewed by the Council’s Citizen 

Science Committee. The January 31, 

2018 meeting will bring all members of 

all five Action Teams together to review 

and discuss draft recommendations 

from each Action Team. Public 

comment will be accepted at the 

beginning of the meeting. 

Items to be addressed during these 

meetings: 

1. Overview and discussion of Action 

Team draft recommendations 

2. Other Business 

Special Accommodations 

These meetings are physically 

accessible to people with disabilities. 

Requests for auxiliary aids should be 

directed to the council office (see 

ADDRESSES) 3 days prior to the meeting. 

Note: The times and sequence specified in 

this agenda are subject to change. 

Authority: 16 U.S.C. 1801 et seq. 

Dated: January 8, 2018. 

Tracey L. Thompson, 

Acting Deputy Director, Office of Sustainable 

Fisheries, National Marine Fisheries Service. 

[FR Doc. 2018–00372 Filed 1–10–18; 8:45 am] 

BILLING CODE 3510–22–P 


srobinson on DSK9F5VC42PROD with NOTICES